Day: October 9, 2023

Safe and Green Development Corporation to Participate in the Virtual Tech Conference Series: Exploring All Corners of the Tech Sector, Presented by Maxim Group LLC on Tuesday, October 10th & Wednesday, October 11th at 8:30 A.M. E.T.

MIAMI, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) — Safe and Green Development Corporation (NASDAQ: SGD)(“SG DevCo” or the “Company”), a leading real estate development company recently spun off from Safe & Green Holdings Corp. (NASDAQ: SGBX) (“SG Holdings”), announced today that Company CFO Nicolai Brune has been invited to present at the conference on Exploring All Corners of the Tech Sector, presented by Maxim Group LLC, on Tuesday, October 10th, & Wednesday, October 11th, 2023, at 8:30 a.m. E.T.   Our company will be taking part in the Virtual Tech Conference Series: Exploring All Corners of the Tech Sector. The continuous evolution of technology is paving the way for innovations across all industries, including financial services, esports, iGaming, entertainment, and more. In the second installment of the 2023 Virtual...

Continue reading

Denny’s Corporation Announces Timing of Third Quarter 2023 Results and Conference Call on October 30, 2023

SPARTANBURG, S.C., Oct. 09, 2023 (GLOBE NEWSWIRE) — Denny’s Corporation (the “Company”) (NASDAQ: DENN), owner and operator of Denny’s Inc. (“Denny’s”) and Keke’s Inc. (“Keke’s”), will announce financial and operating results for its third quarter ended September 27, 2023, on Monday, October 30, 2023, after the markets close. Senior management will hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss these results and answer questions. Interested parties are invited to listen to a live broadcast of the conference call accessible through the Investor Relations section of the Company’s website at investor.dennys.com. For any questions, please contact the Company’s Investor Relations Department at 877-784-7167. About Denny’s Corporation Denny’s Corporation...

Continue reading

Fortress Biotech Announces Reverse Stock Split

MIAMI, Oct. 09, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or the “Company”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, announced that it will effect a 1-for-15 reverse stock split of its issued and outstanding common stock. Fortress expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement of trading on October 10, 2023. The reverse stock split was approved on August 10, 2023 by Fortress’ Board of Directors and by Fortress’ stockholders at a special meeting held on October 9, 2023, with the authorization to determine the final ratio (within a specified range) having been granted to the Company’s Board of Directors....

Continue reading

EXEL Industries: Daniel Tragus will be appointed CEO of EXEL Industries at the Board meeting on December 20th, 2023

Daniel Tragus will be appointed CEO of EXEL Industries at the Board meeting on December 20th, 2023 Under the chairmanship of Mr. Patrick Ballu, EXEL Industries’ Board of Directors has chosen Daniel Tragus to succeed Yves Belegaud as Chief Executive Officer. CEO of EXEL Industries since December 2019, Yves Belegaud gave notice of his intention to retire by the beginning of 2024. In this context, Daniel Tragus, current Deputy Chief Executive Officer in charge of strategy, M&A, and Industrial Property, has been chosen by the Board to succeed him. An ICAM engineer and graduated with an Executive MBA from HEC Paris, Daniel Tragus has worked his whole career for different companies of the EXEL Industries Group. From 1988, he held various technical and managerial position at Kremlin, a global leader in industrial spraying. In 1999,...

Continue reading

Verizon Business brings 5G Innovation Sessions to SoFi Stadium

Verizon and Samsung to showcase the latest in 5G innovations for businesses at SoFi Stadium in Los Angeles on October 11th BASKING RIDGE, N.J., Oct. 09, 2023 (GLOBE NEWSWIRE) — Verizon Business, along with Samsung, is heading to Los Angeles to showcase the power of 5G through dynamic, immersive demonstrations of current and forward-looking use cases and products during this 5G Innovation Sessions tour stop on October 11. Set in the state-of-the-art SoFi Stadium, the event will feature demonstrations, presentations, and panels with industry leaders and experts from Verizon Business and Samsung highlighting Verizon Business’ solutions for businesses. “We’re looking forward to heading back to SoFi Stadium, a perfect example of advanced wireless networks as a catalyst for innovation in sports venues,” said Debika Bhattacharya, Chief...

Continue reading

Hermès International: Shares and voting rights as of 30th September 2023

RELEASE Paris, October 9, 2023 INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES COMPRISING THE SHARE CAPITAL In accordance with the provisions of Article L. 233-8 of the French Commercial Code (Code de commerce) and Article 223-16 of the General Regulations of French Autorité des Marchés Financiers (AMF), Hermès international publishes each month, before the 15th day of the following month, the total number of voting rights and the number of shares comprising the share capital if they have varied from those previously published. Date Total number of shares Total number of theoretical voting rights (including treasury stock) Total number of effective voting rights (exercisable at shareholders’ meetings) Publications 30 September 2023 105 569 412 179 371 032 178 566 482 9 October 2023 31 August 2023 105 569...

Continue reading

Total number of shares and voting rights at September 30, 2023

9 October 2023 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at least two years. Date Number of shares Number of treasury shares without voting rights Theoretical number of voting rights [1] Number of voting rights exercisable 01/31/2023 2, 660, 056,599 1, 655,051 3, 122, 030,612 3, 120, 375,561 02/28/2023 2, 660, 056,599 1, 281,171 3, 121, 957,722 3, 120, 676,551 03/31/2023 2, 660, 056,599 613,910 3,...

Continue reading

Court of Appeal in London rules in favor of Fnac Darty in proceedings relating to the disposal of Comet

Ivry-sur-Seine, France, October 9, 2023 Court of Appeal in London rules in favor of Fnac Darty in proceedings relating to the disposal of Comet In a judgment published today, the Court of Appeal in London unanimously allowed an appeal by Darty Holdings SAS (Darty), a subsidiary of the Fnac Darty group, in the context of litigation relating to the disposal of Comet Group Limited in 2012. Now that the Court of Appeal has overturned the High Court’s first instance decision, the Group should be entitled to repayment of all sums paid by Darty before the end of the year, as well as the reimbursement of interest and legal costs incurred, representing a positive cash impact estimated at around €130 million. In November 2022, the High Court in London issued a first instance judgment in favour of Comet’s liquidator. The Fnac Darty group...

Continue reading

Kineta to Present Preclinical Data on VISTA Blocking KVA12123 at Immuno US 2023

SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that it will present at the Oxford Global Immuno US 2023, to be held on October 12-13, 2023 in San Diego, CA. Thierry Guillaudeux, Ph.D., Chief Scientific Officer of Kineta, will present a preclinical overview of KVA12123, the company’s novel VISTA blocking immunotherapy, currently being evaluated in a Phase 1/2 clinical trial in patients with advanced solid tumors. Presentation Details:Presentation Title: Anti-VISTA Monoclonal Antibody ProgramSession: Discovery & Development: Cell Therapies & Antibody ApproachesSession location: Conference Room 3 Presenter: Thierry Guillaudeux, Ph.D. Date / Time:...

Continue reading

BioRestorative Therapies, Inc. to Participate at the ROTH MKM Healthcare Opportunities Conference October 12, 2023 in New York City

MELVILLE, NY., Oct. 09, 2023 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRetorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, announced today that Company CEO, Lance Alstodt, has been invited to present at the ROTH MKM Healthcare Opportunities Conference.     Company            BioRestorative Therapies, Inc.Presenter            Lance Alstodt, Chief Executive OfficerDate & Time        Thursday October 12th, 9:00am estLocation              Yale Club, 50 Vanderbilt Avenue, NYC If you are interested in requesting a one-on-one meeting at the conference, please contact your bank/conference representative. About BioRestorative Therapies, Inc. BioRestorative Therapies, Inc. (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.